baber/WOPTO huggingface dataset:
Patent NZ-550360-A (NZ)
Title: Pole mounting system and method
Inventor: WELLS ROBBIE DAVID
Filed: 2006-10-06
Abstract: A pole mounting system for attaching auxiliary equipment (2) to street poles (1) is disclosed. The system includes a pair of substantially part cylindrical clamps (12) and tightening means to advance the clamps (12) towards each other, and thereby grasp an elongate pole (1) about a substantially transverse cross-section. Each of the clamps (12) includes a plurality of spaced apart locator sites (21) extending therearound. The auxiliary equipment includes an upper engagement portion (26) which has at least one aperture for receiving a locking pin therethrough for engagement with one of the locator sites (21) on one of the clamps (12). The attachment can be temporarily supported by interengagement of the locking pin through the upper engagement portion (26) aperture and clamp(s) (12). The radial positioning of the auxiliary equipment (2) can therefore be verified before the auxiliary equipment (2) is secured to the clamps (12). (61) Addition to 540329
Patent NZ-552607-A (NZ)
Title: Prognostic molecular markers
Inventor: COSTA RAFAEL ROSELL
Filed: 2005-07-11
Abstract: Disclosed is the use of Ecteinascidin 743 (ET-743) in the manufacture of a medicament for the treatment of cancer in a patient, wherein BRCA1 gene expression levels measured in a collection of biological samples from cancer patients suffering from the same type of cancer in the absence of ET-743 treatment.
Patent NZ-555707-A (NZ)
Title: Process to improve activity of mannoprotein as wine stabiliser
Inventor: LANKHORST PETER PHILIP
IPC: C12H1/14
Filed: 2005-12-20
Abstract: Disclosed is a process to improve the activity of a mannoprotein as wine stabiliser, the process comprising treating a mannoprotein with a basic solution at a pH of at least 10.
Patent NZ-556217-A (NZ)
Title: System and method for filtering electromagnetic transmissions
Inventor: SIMPSON DERON
IPC: H01J29/06
Filed: 2006-01-12
Abstract: A method for reducing electromagnetic and radio frequency interference is disclosed. The method includes reducing an amount of electromagnetic interference and radio frequency interference within an enclosure having transparent areas by blocking or attenuating passage of electromagnetic or radio interference entering the enclosure. This is done by applying an optically transparent filter having an electrically conductive metal layer to the transparent areas of the enclosure, thereby blocking or attenuating the passage of the electromagnetic and radio frequency interference through the transparent areas.
Patent NZ-560270-A (NZ)
Title: Apparatus and method for radiation processing of fluent food products
Inventor: PATEL SHEKHAR
IPC: A23C3/07
Filed: 2006-02-08
Abstract: Disclosed is an apparatus for radiation processing of fluent food products comprising: a radiation source; a first wall having a convex surface, the first wall being transmissive to radiation energy produced by the radiation source; a second wall having a surface that opposes the convex surface of the first wall so as to form a product flow cavity therebetween; an inlet forming a passageway into the product flow cavity; an outlet forming a passageway out of the product flow cavity; and a sensor means in the product flow cavity for measuring a characteristic of the radiation energy emitted by the radiation source; wherein the first wall is positioned between the radiation source and the product flow cavity so that when the radiation source emits radiation energy, the radiation energy passes through the first wall and into the product flow cavity, and wherein the radiation source is selected from a group consisting of an electron beam source, a gamma ray source, or an x-ray source. Also disclosed is a method of processing fluent food products by radiation, using the above apparatus.
Patent NZ-563460-A (NZ)
Title: Improved bunion cushion
Inventor: BAYLY MARK
IPC: A61F13/06
Filed: 2006-05-04
Abstract: Disclosed is a bunion cushion (2). The cushion comprises securing means (6) for securing the bunion cushion adjacent the skin of a user, where a surface extends over the securing means and has one or more protrusions extending therefrom. The surface, in use, is placed adjacent the skin of a user of the bunion cushion.
Patent NZ-572842-A (NZ)
Title: Hemangio-colony forming cells
Inventor: LANZA ROBERT
IPC: C12N5/0789
Filed: 2007-04-13
Abstract: Disclosed is an in vitro method for generating and expanding human hemangio-colony forming cells that are at least bi-potential, said method comprising the steps of: a) culturing a cell culture comprising human embryo-derived cells in serum-free media in the presence of at least one growth factor selected from the group consisting of vascular endothelial growth factor (VEGF), bone morphogenic proteins (BMP), and combinations thereof, in an amount sufficient to induce the differentiation of said embryo-derived cells into embryoid bodies; and b) adding at least one growth factor selected from the group consisting of basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), bone morphogenic proteins (BMP) , stem cell factor (SCF) , Flt-3L (FL), thrombopoietin (TPO) , erythropoietin (EPO) , a homeobox protein, HOXB4 protein or a functional equivalent or an active fragment of a homeobox or HOXB4 protein that binds to the same or similar nucleic acid sequences as wild-type HOXB4, and combinations thereof, to said culture comprising embryoid bodies, wherein said growth factor is in an amount sufficient to expand human hemangio-colony forming cells in said embryoid bodies culture, wherein said embryo-derived cells, embryoid bodies and hemangio-colony forming cells are continuously grown in serum-free media throughout steps (a) and (b) of said method.
Patent NZ-579918-A (NZ)
Title: 5-{4-[2-(4-fluoro-benzyl)-3-oxo-cyclohex-1-enylamine]-2,3-difluoro-phenyl}-4,4-dimethyl-2,4-dihydro-pyrazol-3-one to reduce unsightly cellulite
Inventor: ALEOTTI ALBERTO
IPC: A61K31/4155
Filed: 2008-03-20
Abstract: Disclosed is compound 5-{4-[2-(4-fluoro-benzyl)-3-oxo-cyclohex-1-enylamine]-2,3-difluoro-phenyl}-4,4-dimethyl-2,4-dihydro-pyrazol-3-one of a specific formula as defined in the specification. Further disclosed is the use of the compound for the treatment of cellulite.
Patent NZ-581212-A (NZ)
Title: Skin whitening agent comprising lactoferrins, a metal, carbonic acid and bicarbonic acid as active ingredients
Inventor: WATANABE TATSUYA
IPC: A23L33/18
Filed: 2008-05-22
Abstract: Disclosed is a skin whitening agent comprising, as an active ingredient, a complex of carbonic acid and/or bicarbonic acid, a metal and an LF, a decomposition product of the complex, or a complex of carbonic acid and/or bicarbonic acid, a metal and a decomposition product of an LF; and a food, beverage, feed or cosmetic comprising the skin whitening agent. The skin whitening agent can be ingested safely on a daily basis, and exhibits a skin whitening effect.
Patent NZ-584753-A (NZ)
Title: Imidazo (1,2-a)pyridine compounds as VEGF-R2 inhibitors
Inventor: BARDA DAVID ANTHONY
IPC: A61K31/4375
Filed: 2006-02-23
Abstract: Disclosed is a imidazol[1,2-a]pyridinyl compound of formula (I) where the substituents are as disclosed in the description provided that the compound is not 2-{2-fluoro-4-[7-(2-methyl-pyridin-4-yl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-N-(3-trifluoromethyl-phenyl)-acetamide. Also disclosed is a pharmaceutical formulation containing a compound of formula (I) and the use of a compound of formula (I) for the manufacture of a medicament to block angiogenesis or to treat susceptible neoplasms. (62) Divided Out of 560402
Patent NZ-586332-A (NZ)
Title: Therapeutic regimens for the treatment of immunoinflammatory disorders using dipyridamole and prednisolone
Inventor: PADVAL MAHESH V
IPC: A61K9/36
Filed: 2008-12-17
Abstract: Disclosed is the use of a dipyridamole and prednisolone in the manfacture of a unit dosage form formulated for oral administration in the treatment of an immunoinflammatory disorder in a subject in need thereof, wherein said unit dosage form: (i) between 40 and 400 mg dipyridamole formulated for controlled release, and (ii) from 0.75 to 3.75 mg of prednisolone, wherein 50% to 80% of said prednisolone is formulated for immediate release and 20% to 50% of said prednisolone is formulated for controlled release.
Patent NZ-587054-A (NZ)
Title: Color clear coated stainless steel sheet containing a pigment and method for production of the same
Inventor: FUKAYA MASUHIRO
IPC: C09D7/41
Filed: 2009-02-02
Abstract: A colour clear coated stainless steel sheet (10) is disclosed including a stainless steel base sheet (11) and a colour clear coating film (13). The colour clear coating film (13) is formed on at least one side of the stainless steel base sheet (11) and contains a pigment. The pigment volume concentration is in a range of 0.5 to 5.0% and a dispersion particle size of the pigment is in a range of 10 to 25 µm. The pigment is either an inorganic pigment having a mean primary particle diameter in a range of 100 to 200 nm, a carbon pigment having a mean primary particle diameter in a range of 10 to 80 nm or an organic pigment having a mean primary particle diameter in a range of 50 to 1100 nm.
Patent NZ-588479-A (NZ)
Title: Combination therapy comprising an antibody which binds and inhibits activity of both hb-egf and areg
Inventor: CASWELL JILL
IPC: A61P35/00
Filed: 2009-04-17
Abstract: Discloses a polyspecific antibody which binds Heparin-binding EGF-like growth factor (HBEGF) and amphiregulin (AREG) and inhibits the activity of both HBEGF and AREG. The polyspecific antibody has a VH domain with 3 CDRs from SEQ ID NO: 7 and a VL domain with 3 CDRs from SEQ ID NO: 8. Further disclosed is the use of the polyspecific antibody in the preparation of a medicament for treatment of a neoplastic disease or inflammatory associated disorder. The use of the antibody may be in combination with a selected chemotherapeutic agent or angiogenesis inhibitor. Further disclosed is a kit comprising (i) the polyspecific antibody and (ii) selected chemotherapeutic agent or angiogenesis inhibitor.
Patent NZ-590687-A (NZ)
Title: A control device, and method, for controlling the location of an animal
Inventor: REED MATTHEW
IPC: A01K15/00
Filed: 2009-07-24
Abstract: 590687 Disclosed is a control device (22) for controlling the location of an animal. The control device (22) includes a GPS receiver (20) for receiving GPS signals, and a processor (24) communicatively coupled to the GPS receiver (20) which continuously determines the position, velocity and heading direction of the animal relative to a target. A stimulus unit (34) applies selective stimuli to the animal in response to signals received from the processor (24). The processor (24) is programmable such that if the position, velocity and the heading direction of the animal are within predetermined values relative to the target, then a signal indicative of applying a non-aversive stimulus to the animal is generated. The processor (24) is selectively programmable such that when the velocity of the animal relative to the target is outside of the predetermined range or the heading direction of the animal changes by more than a predetermined amount a signal indicative of removal of the non-aversive stimulus is generated. Otherwise, a signal is generated indicative of first removing the non-aversive stimulus followed by application of an aversive stimulus to the animal.
Patent NZ-597994-A (NZ)
Title: Nitrogen-containing spiro-ring compound and medicinal use of same
Inventor: MIURA TOMOYA
IPC: A61K31/437
Filed: 2010-07-30
Abstract: Disclosed is a compound of formula I wherein Ra is the same or different and each: (1) C1-6 alkyl, or (2) halogen atom, n1 is an integer selected from 0 to 4, Rb is the same or different and each: (1) C1-6 alkyl, or (2) halogen atom, n2 is an integer selected from 0 to 4, M1 is an integer selected from 0 to 3, m2 is an integer selected from 1 to 4, Xa=Xb is: (1) CH=CH, (2) N=CH, or (3) CH=N, X is: (1) nitrogen atom, or (2) C-Rd wherein Rd is hydrogen atom or halogen atom, RC is a group selected from the following (1) to (6): (1) hydrogen atom, (2) C'-6 alkyl optionally substituted by the same or different 1 to 5 substituents selected from the following Group A, (3) -C(=O)-Rc1,(4) -C(=O)-O-Rc2, (5) -C(=O)-NRC3Rc4 in which Rc1, Rc2, Rc3 and Rc4 are the same or different and each: (i) hydrogen atom, or (ii) C1-6 alkyl optionally substituted by the same or different 1 to 5 substituents selected from the following Group A, or (6) a group of formula 2 in which Ya is a group selected from the following (i) to (iii): (i) C1-6 alkylene, (ii) -C(=O)-, or (iii) -C(=O)-O-, Ring T is: (i) C6-10 aryl, (ii) C3-10 cycloalkyl, or (iii) saturated monoheterocyclyl wherein the saturated monoheterocyclyl comprises 1 to 4 heteroatoms selected from nitrogen atom, oxygen atom or sulfur atom as well as carbon atoms and the number of the constituent ring atoms is 3 to 7, Rc5 is the same or different and each: (i) cyano, or nitro, p is an integer selected from 0 to 4, group A is the group consisting of: (a) hydroxyl, (b) C1-6 alkoxy, (c) cyano,(d) C1-6 alkoxycarbonyl, (e) C1-6 alkylcarbonyloxy, and (f) C2-6 alkenyloxy, or a pharmaceutically acceptable salt thereof, or a solvate thereof. The compound is useful for treating organ transplant rejection, autoimmune diseases, allergic diseases and cancers.
Patent NZ-600134-A (NZ)
Title: Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
Inventor: BENJAMIN RODNEY
IPC: C12H6/00
Filed: 2010-10-29
Abstract: Disclosed is the use of a therapeutically effective amount of methylsulfonylmethane (MSM) and a therapeutically effective amount of a Beta-lactam antibiotic that inhibits a drug-sensitive form of a drug-resistant bacterial pathogen (such as a penicillin derivative, a cephalosporin, a penem, a monobactam, a carbapenem or a Beta-lactamase inhibitor, and particularly methicillin or oxacillin) in the manufacture of a medicament for inhibiting a disease or condition caused by a bacterial pathogen, and particularly wherein the bacterial pathogen is methicillin resistant Staphylococcus aureus (MRSA). Also disclosed is the use of a therapeutically effective amount of methylsulfonylmethane (MSM) and a therapeutically effective amount of a ß-lactam antibiotic in the manufacture of a medicament for treating a disease or condition caused by a bacterial pathogen whereby the medicament sensitizes the drug resistant bacterial pathogen to a drug to which the bacterial pathogen is resistant. Additionally, the use of a therapeutically effective amount of methylsulfonylmethane (MSM) and a therapeutically effective amount of a Beta-lactam antibiotic in the manufacture of a medicament for treating a disease or condition caused by a bacterial pathogen whereby the medicament inhibits a drug-sensitive bacterial pathogen from developing drug resistance.
Patent NZ-600225-A (NZ)
Title: Fouling detection setup and method to detect fouling
Inventor: KRACK RALF
IPC: B01D65/10
Filed: 2009-12-11
Abstract: 600225 The invention refers to a fouling detection setup (1) and method for determining the amount of fouling (5) of surfaces (3) of fluid (6) treating devices (2) and/or internal functional components (4) of devices, which are exposed to the fluid and are subjected to fouling. Fouling detection setups and methods are useful for monitoring the amount of fouling of surfaces, e.g. heat-transfer surfaces and also for monitoring the cleaning procedure of fluid treating devices and/or internal functional components of devices. The detection setup (1) comprises at least one first sensor (7), which comprises means (9) for measuring the optical transparency T and/or electrical conductive conductivity Q of the fluid (6) including at least one sensitive area (8) that is located within the surfaces (3) and wherein the area is at least temporarily exposed to the fluid (6). The area (8) of the measuring sensor (7), comprises at least one first electrically conductive surface (10), and the sensor (7) further comprises a second electrically conductive surface (11), which is at least temporarily exposed to the fluid, preferably located within the area (8), but spatially separated to the first electrically conductive surface (10).
Patent NZ-601631-A (NZ)
Title: Sunscreen compositions comprising an ultraviolet radiation-absorbing polymer
Inventor: COLE CURTIS
IPC: A61Q1/02
Filed: 2011-02-07
Abstract: Disclosed is a composition, comprising: a continuous water phase; a discontinuous oil phase comprising a UV-absorbing polyester that is formed by a polycondensation reaction of dimerdiol (DD36 CAS No. 147853-32-5, which is a C36 diol) as a first monomer (monomer 1), di(trimethylolpropane) as a second monomer (monomer 2), dimethyladipate as a third monomer (monomer 3) and benzenepropanoic acid, 3-(2h-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-, methylester (methyl 3-[3-tert-butyl-5-(2H-benzotriazol-2-yl)-4-hydroxyphenyl]propionate / methyl 3-(3-(2H-benzotriazol-2-yl)-5-tertbutyl-4-hydroxyphenyl)propionate) (monomer 4), in an amount effective to provide said composition with an SPF of about 2 or more in the absence of a UV-screening compound, wherein the mole ratio of the four monomers (monomer 1:monomer 2:monomer 3:monomer 4) is selected from the group consisting of 2.4:3.1:4.0:8.0 and 3.4:2.1:4.0:6.0; wherein said discontinuous oil phase is stable in said continuous water phase; and an oil-gelling polymer, wherein said composition is substantially free of a non-polymeric UV-absorber.
Patent NZ-601990-A (NZ)
Title: Method for producing and processing wood chips
Inventor: HELLSTROM LISBETH
IPC: B02C18/18
Filed: 2011-03-02
Abstract: 601990 A method to produce wood chips with the intention of reducing the energy consumption in the subsequent process steps for pulp production is disclosed. The method chips wood (1) in a wood chipper where the chipping tool (3) has an angle ? (4) within an interval of 75 degree to 105 degree between the fibre direction of the log and the side of the tool which faces the chip (2). Angles in this interval will cause an axially directed compression of the chip which will cause a cracking of the wood during chipping. This in turn will reduce the energy consumption in the subsequent process steps.
Patent NZ-602670-A (NZ)
Title: Non-nucleoside reverse transcriptase inhibitors
Inventor: BURCH JASON
IPC: A61K31/4196
Filed: 2011-03-28
Abstract: Disclosed is a compound which is doravirine (MK-1439 / 3-chloro-5-({ 1-[(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl} oxy)benzonitrile). Further disclosed is a pharmaceutical composition comprising an effective amount of doravirine and a pharmaceutically acceptable carrier for the treatment of infection by HIV or for the treatment of AIDS in a subject in need thereof.
Patent NZ-606988-A (NZ)
Title: Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
Inventor: EPSHTEIN OLEG ILIICH
IPC: C07K16/40
Filed: 2011-07-15
Abstract: Disclosed is a combination pharmaceutical composition comprising: a) a homeopathic activated-potentiated form of an antibody to brain-specific protein S-100; and b) a homeopathic activated-potentiated form of an antibody to endothelial NO synthase. Also disclosed is the use of a) a homeopathic activated-potentiated form of an antibody to brain-specific protein S-100; and b) a homeopathic activated-potentiated form of an antibody to endothelial NO synthase in the manufacture of a medicament for the treatment of vertigo of various genesis, kinetosis and vegetative-vascular dystonia.
Patent NZ-611166-A (NZ)
Title: Lift installation comprising car and counterweight
Inventor: HUSMANN JOSEF
IPC: B66B5/22
Filed: 2011-12-09
Abstract: 611166 The disclosure relates to a lift installation comprising a car (2), a counterweight (3) and safeties (11, 11a, 11b, 11g) which are fitted to the car (2) and the counterweight (3). The car (2) contains an electrically controlled device for actuating and optionally resetting the safety (14, 14a, 14b) and the counterweight (3) also contains an electrically controlled device with a safety (11, 11g), or the safety (11, 11g) of the counterweight (3) is actuated by means of a slack-line release (56).
Patent NZ-614681-A (NZ)
Title: Living plant display and storage system, apparatus and method
Inventor: Brad Stebbing
IPC: A01G9/04
Filed: 2013-08-23
Abstract: 614681 A modular plant on display and storage (PODS) system has an inner container to contain a plant with a base and volume, and an outer container for receiving growing medium or water seepage from the inner container. In turn the inner and outer container are placed in a shell so that the system provides a customisable storage system for one or more plants upright and collects seepage.
Patent NZ-616170-A (NZ)
Title: Mixer drum driving device
Inventor: TAKAHASHI YOSHIMITSU
IPC: B60P3/16
Filed: 2012-03-15
Abstract: The mixer drum driving device S includes a hydraulic motor 3, hydraulic pump 4, auxiliary hydraulic pump 5, and a direct current brush motor 6. The hydraulic motor 3 drives and rotates the mixer drum M. The hydraulic pump 4 supplies pressure oil to the hydraulic motor 3 via switching valve 20 and main hydraulic line 8 by being driven by the power of an engine E of the mixer truck. The auxiliary hydraulic pump 5 rotates the mixer drum M by supplying pressure oil to the hydraulic motor 3 independently of the hydraulic pump 4. The direct current brush motor 6 drives and rotates the auxiliary hydraulic pump 5. The mixer drum M is driven and rotated by driving only the auxiliary hydraulic pump 5 by the direct current brush motor 6 in the case of rotating the mixer drum M for mixing, and whilst the hydraulic pump 5 is supplying pressure oil to the hydraulic motor 3, the switching valve 20 is set to position 20c so that the hydraulic pump 4 is disconnected from the hydraulic motor 3.
Patent NZ-617570-A (NZ)
Title: Device and method for draining and rinsing containers filled with fluid
Inventor: HUBER ROBERT
IPC: B09B3/00
Filed: 2012-05-16
Abstract: A method for draining and rinsing containers filled with fluid, in which the container is received by a receiving unit 4. The receiving unit 4 comprises a rotation device by means of which the container, after insertion into the receiving unit 4, is rotated by a predetermined angle. A removal opening 2 of the container 1 is connected to a coupling 8 of a removal line 9, and the fluid located in the container 1 is conveyed out of the container 1. After the draining of the container 1, a wall 7 of the container 1 is automatically pierced by a rinsing spike 14, and the container 1 is rinsed out with a rinsing liquid by means of a rinsing line 17 connected to the rinsing spike 14. The container is rotatable by means of the rotation device about an axis which is oriented in a range of +/- 20º around the horizontal.
Patent NZ-618301-A (NZ)
Title: Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme
Inventor: VAUGHN DANIEL EDWARD
IPC: A61P5/50
Filed: 2012-06-15
Abstract: Disclosed is the use of a composition comprising a hyaluronidase and a composition comprising an insulin for manufacture of a medicament for treatment of diabetes in combination with continuous subcutaneous insulin infusion (CSII) to minimize changes in insulin absorption that occur during a course of CSII therapy, wherein: -the composition comprising the insulin is formulated for continuous subcutaneous insulin infusion (CSII) therapy to be administered for more than one day; -the composition comprising the hyaluronidase is formulated to be administered as a single dose bolus injection for administration separately from the insulin in the CSII therapy prior to infusion of the insulin composition by CSII; and -the composition comprising the hyaluronidase is formulated for direct administration in an amount that minimizes changes in insulin absorption that occurs over a course of continuous subcutaneous insulin infusion (CSII).